カテゴリー： 世界, 医療/バイオ, LP Information

世界のパリペリドン徐放性錠剤市場予測 2023年-2029年

【英語タイトル】Global Paliperidone Extended Release Tablets Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC02974）・商品コード：LP23DC02974
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：95
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のパリペリドン徐放性錠剤市場」は、過去の販売実績から2022年の世界のパリペリドン徐放性錠剤の総販売量を検討し、2023年から2029年の予測されるパリペリドン徐放性錠剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のパリペリドン徐放性錠剤の市場規模を掲載し、XXX百万米ドル規模の世界のパリペリドン徐放性錠剤市場の詳細な分析を提供します。本インサイトレポートは、世界のパリペリドン徐放性錠剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のパリペリドン徐放性錠剤市場における各社の独自のポジションをより深く理解するために、パリペリドン徐放性錠剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のパリペリドン徐放性錠剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。パリペリドン徐放性錠剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。パリペリドン徐放性錠剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。パリペリドン徐放性錠剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

パリペリドン徐放性錠剤の世界主要メーカーとしては、Janssen Pharmaceutical、 Cspc Ouyi Pharmaceutical Co., Ltd.、 Hansoh Pharmaceutical Group Company Limited、 Shenzhen Kangzhe Biotechnology Co., Ltd.、 Haisco Pharmaceutical Group Co., Ltd.、 Sun Pharmaceutical、 Teva、 Lupinなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のパリペリドン徐放性錠剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではパリペリドン徐放性錠剤市場をセグメンテーションし、種類別 (3mg、6mg)、用途別 (病院、精神病院、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：3mg、6mg

・用途別区分：病院、精神病院、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のパリペリドン徐放性錠剤市場の10年間の市場状況・展望は？
・世界および地域別に見たパリペリドン徐放性錠剤市場成長の要因は何か？
・パリペリドン徐放性錠剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・パリペリドン徐放性錠剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：パリペリドン徐放性錠剤の年間販売量2018-2029、地域別現状・将来分析
・パリペリドン徐放性錠剤の種類別セグメント：3mg、6mg
・パリペリドン徐放性錠剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・パリペリドン徐放性錠剤の用途別セグメント：病院、精神病院、その他
・パリペリドン徐放性錠剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のパリペリドン徐放性錠剤市場
・企業別のグローバルパリペリドン徐放性錠剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別のパリペリドン徐放性錠剤の年間売上：2018-2023年の売上、市場シェア
・企業別のパリペリドン徐放性錠剤販売価格
・主要企業のパリペリドン徐放性錠剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

パリペリドン徐放性錠剤の地域別レビュー
・地域別のパリペリドン徐放性錠剤市場規模2018-2023：年間販売量、売上
・主要国別のパリペリドン徐放性錠剤市場規模2018-2023：年間販売量、売上
・南北アメリカのパリペリドン徐放性錠剤販売の成長
・アジア太平洋のパリペリドン徐放性錠剤販売の成長
・ヨーロッパのパリペリドン徐放性錠剤販売の成長
・中東・アフリカのパリペリドン徐放性錠剤販売の成長

南北アメリカ市場
・南北アメリカの国別のパリペリドン徐放性錠剤販売量、売上（2018-2023）
・南北アメリカのパリペリドン徐放性錠剤の種類別販売量
・南北アメリカのパリペリドン徐放性錠剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のパリペリドン徐放性錠剤販売量、売上（2018-2023）
・アジア太平洋のパリペリドン徐放性錠剤の種類別販売量
・アジア太平洋のパリペリドン徐放性錠剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のパリペリドン徐放性錠剤販売量、売上（2018-2023）
・ヨーロッパのパリペリドン徐放性錠剤の種類別販売量
・ヨーロッパのパリペリドン徐放性錠剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のパリペリドン徐放性錠剤販売量、売上（2018-2023）
・中東・アフリカのパリペリドン徐放性錠剤の種類別販売量
・中東・アフリカのパリペリドン徐放性錠剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・パリペリドン徐放性錠剤の製造コスト構造分析
・パリペリドン徐放性錠剤の製造プロセス分析
・パリペリドン徐放性錠剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・パリペリドン徐放性錠剤の主要なグローバル販売業者
・パリペリドン徐放性錠剤の主要なグローバル顧客

地域別のパリペリドン徐放性錠剤市場予測レビュー
・地域別のパリペリドン徐放性錠剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・パリペリドン徐放性錠剤の種類別市場規模予測
・パリペリドン徐放性錠剤の用途別市場規模予測

主要企業分析
Janssen Pharmaceutical、 Cspc Ouyi Pharmaceutical Co., Ltd.、 Hansoh Pharmaceutical Group Company Limited、 Shenzhen Kangzhe Biotechnology Co., Ltd.、 Haisco Pharmaceutical Group Co., Ltd.、 Sun Pharmaceutical、 Teva、 Lupin
・企業情報
・パリペリドン徐放性錠剤製品
・パリペリドン徐放性錠剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Paliperidone Extended Release Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Paliperidone Extended Release Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Paliperidone Extended Release Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Paliperidone Extended Release Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Paliperidone Extended Release Tablets players cover Janssen Pharmaceutical, Cspc Ouyi Pharmaceutical Co., Ltd., Hansoh Pharmaceutical Group Company Limited, Shenzhen Kangzhe Biotechnology Co., Ltd., Haisco Pharmaceutical Group Co., Ltd., Sun Pharmaceutical, Teva and Lupin, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Paliperidone Extended Release Tablets Industry Forecast” looks at past sales and reviews total world Paliperidone Extended Release Tablets sales in 2022, providing a comprehensive analysis by region and market sector of projected Paliperidone Extended Release Tablets sales for 2023 through 2029. With Paliperidone Extended Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paliperidone Extended Release Tablets industry.
This Insight Report provides a comprehensive analysis of the global Paliperidone Extended Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paliperidone Extended Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Paliperidone Extended Release Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paliperidone Extended Release Tablets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paliperidone Extended Release Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Paliperidone Extended Release Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
3mg
6mg
Segmentation by application
Hospital
Psychiatric Hospital
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Janssen Pharmaceutical
Cspc Ouyi Pharmaceutical Co., Ltd.
Hansoh Pharmaceutical Group Company Limited
Shenzhen Kangzhe Biotechnology Co., Ltd.
Haisco Pharmaceutical Group Co., Ltd.
Sun Pharmaceutical
Teva
Lupin
Key Questions Addressed in this Report
What is the 10-year outlook for the global Paliperidone Extended Release Tablets market?
What factors are driving Paliperidone Extended Release Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Paliperidone Extended Release Tablets market opportunities vary by end market size?
How does Paliperidone Extended Release Tablets break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Paliperidone Extended Release Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Paliperidone Extended Release Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Paliperidone Extended Release Tablets by Country/Region, 2018, 2022 & 2029
2.2 Paliperidone Extended Release Tablets Segment by Type
2.2.1 3mg
2.2.2 6mg
2.3 Paliperidone Extended Release Tablets Sales by Type
2.3.1 Global Paliperidone Extended Release Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Paliperidone Extended Release Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Paliperidone Extended Release Tablets Sale Price by Type (2018-2023)
2.4 Paliperidone Extended Release Tablets Segment by Application
2.4.1 Hospital
2.4.2 Psychiatric Hospital
2.4.3 Other
2.5 Paliperidone Extended Release Tablets Sales by Application
2.5.1 Global Paliperidone Extended Release Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Paliperidone Extended Release Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Paliperidone Extended Release Tablets Sale Price by Application (2018-2023)
3 Global Paliperidone Extended Release Tablets by Company
3.1 Global Paliperidone Extended Release Tablets Breakdown Data by Company
3.1.1 Global Paliperidone Extended Release Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Paliperidone Extended Release Tablets Sales Market Share by Company (2018-2023)
3.2 Global Paliperidone Extended Release Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Paliperidone Extended Release Tablets Revenue by Company (2018-2023)
3.2.2 Global Paliperidone Extended Release Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Paliperidone Extended Release Tablets Sale Price by Company
3.4 Key Manufacturers Paliperidone Extended Release Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paliperidone Extended Release Tablets Product Location Distribution
3.4.2 Players Paliperidone Extended Release Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Paliperidone Extended Release Tablets by Geographic Region
4.1 World Historic Paliperidone Extended Release Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Paliperidone Extended Release Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Paliperidone Extended Release Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Paliperidone Extended Release Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Paliperidone Extended Release Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Paliperidone Extended Release Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Paliperidone Extended Release Tablets Sales Growth
4.4 APAC Paliperidone Extended Release Tablets Sales Growth
4.5 Europe Paliperidone Extended Release Tablets Sales Growth
4.6 Middle East & Africa Paliperidone Extended Release Tablets Sales Growth
5 Americas
5.1 Americas Paliperidone Extended Release Tablets Sales by Country
5.1.1 Americas Paliperidone Extended Release Tablets Sales by Country (2018-2023)
5.1.2 Americas Paliperidone Extended Release Tablets Revenue by Country (2018-2023)
5.2 Americas Paliperidone Extended Release Tablets Sales by Type
5.3 Americas Paliperidone Extended Release Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paliperidone Extended Release Tablets Sales by Region
6.1.1 APAC Paliperidone Extended Release Tablets Sales by Region (2018-2023)
6.1.2 APAC Paliperidone Extended Release Tablets Revenue by Region (2018-2023)
6.2 APAC Paliperidone Extended Release Tablets Sales by Type
6.3 APAC Paliperidone Extended Release Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Paliperidone Extended Release Tablets by Country
7.1.1 Europe Paliperidone Extended Release Tablets Sales by Country (2018-2023)
7.1.2 Europe Paliperidone Extended Release Tablets Revenue by Country (2018-2023)
7.2 Europe Paliperidone Extended Release Tablets Sales by Type
7.3 Europe Paliperidone Extended Release Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Paliperidone Extended Release Tablets by Country
8.1.1 Middle East & Africa Paliperidone Extended Release Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Paliperidone Extended Release Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Paliperidone Extended Release Tablets Sales by Type
8.3 Middle East & Africa Paliperidone Extended Release Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paliperidone Extended Release Tablets
10.3 Manufacturing Process Analysis of Paliperidone Extended Release Tablets
10.4 Industry Chain Structure of Paliperidone Extended Release Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paliperidone Extended Release Tablets Distributors
11.3 Paliperidone Extended Release Tablets Customer
12 World Forecast Review for Paliperidone Extended Release Tablets by Geographic Region
12.1 Global Paliperidone Extended Release Tablets Market Size Forecast by Region
12.1.1 Global Paliperidone Extended Release Tablets Forecast by Region (2024-2029)
12.1.2 Global Paliperidone Extended Release Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Paliperidone Extended Release Tablets Forecast by Type
12.7 Global Paliperidone Extended Release Tablets Forecast by Application
13 Key Players Analysis
13.1 Janssen Pharmaceutical
13.1.1 Janssen Pharmaceutical Company Information
13.1.2 Janssen Pharmaceutical Paliperidone Extended Release Tablets Product Portfolios and Specifications
13.1.3 Janssen Pharmaceutical Paliperidone Extended Release Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Janssen Pharmaceutical Main Business Overview
13.1.5 Janssen Pharmaceutical Latest Developments
13.2 Cspc Ouyi Pharmaceutical Co., Ltd.
13.2.1 Cspc Ouyi Pharmaceutical Co., Ltd. Company Information
13.2.2 Cspc Ouyi Pharmaceutical Co., Ltd. Paliperidone Extended Release Tablets Product Portfolios and Specifications
13.2.3 Cspc Ouyi Pharmaceutical Co., Ltd. Paliperidone Extended Release Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cspc Ouyi Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Cspc Ouyi Pharmaceutical Co., Ltd. Latest Developments
13.3 Hansoh Pharmaceutical Group Company Limited
13.3.1 Hansoh Pharmaceutical Group Company Limited Company Information
13.3.2 Hansoh Pharmaceutical Group Company Limited Paliperidone Extended Release Tablets Product Portfolios and Specifications
13.3.3 Hansoh Pharmaceutical Group Company Limited Paliperidone Extended Release Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hansoh Pharmaceutical Group Company Limited Main Business Overview
13.3.5 Hansoh Pharmaceutical Group Company Limited Latest Developments
13.4 Shenzhen Kangzhe Biotechnology Co., Ltd.
13.4.1 Shenzhen Kangzhe Biotechnology Co., Ltd. Company Information
13.4.2 Shenzhen Kangzhe Biotechnology Co., Ltd. Paliperidone Extended Release Tablets Product Portfolios and Specifications
13.4.3 Shenzhen Kangzhe Biotechnology Co., Ltd. Paliperidone Extended Release Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Shenzhen Kangzhe Biotechnology Co., Ltd. Main Business Overview
13.4.5 Shenzhen Kangzhe Biotechnology Co., Ltd. Latest Developments
13.5 Haisco Pharmaceutical Group Co., Ltd.
13.5.1 Haisco Pharmaceutical Group Co., Ltd. Company Information
13.5.2 Haisco Pharmaceutical Group Co., Ltd. Paliperidone Extended Release Tablets Product Portfolios and Specifications
13.5.3 Haisco Pharmaceutical Group Co., Ltd. Paliperidone Extended Release Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Haisco Pharmaceutical Group Co., Ltd. Main Business Overview
13.5.5 Haisco Pharmaceutical Group Co., Ltd. Latest Developments
13.6 Sun Pharmaceutical
13.6.1 Sun Pharmaceutical Company Information
13.6.2 Sun Pharmaceutical Paliperidone Extended Release Tablets Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Paliperidone Extended Release Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sun Pharmaceutical Main Business Overview
13.6.5 Sun Pharmaceutical Latest Developments
13.7 Teva
13.7.1 Teva Company Information
13.7.2 Teva Paliperidone Extended Release Tablets Product Portfolios and Specifications
13.7.3 Teva Paliperidone Extended Release Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Teva Main Business Overview
13.7.5 Teva Latest Developments
13.8 Lupin
13.8.1 Lupin Company Information
13.8.2 Lupin Paliperidone Extended Release Tablets Product Portfolios and Specifications
13.8.3 Lupin Paliperidone Extended Release Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Lupin Main Business Overview
13.8.5 Lupin Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Paliperidone Extended Release Tablets Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Paliperidone Extended Release Tablets Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 3mg
Table 4. Major Players of 6mg
Table 5. Global Paliperidone Extended Release Tablets Sales by Type (2018-2023) & (K Boxes)
Table 6. Global Paliperidone Extended Release Tablets Sales Market Share by Type (2018-2023)
Table 7. Global Paliperidone Extended Release Tablets Revenue by Type (2018-2023) & ($ million)
Table 8. Global Paliperidone Extended Release Tablets Revenue Market Share by Type (2018-2023)
Table 9. Global Paliperidone Extended Release Tablets Sale Price by Type (2018-2023) & (US$/Box)
Table 10. Global Paliperidone Extended Release Tablets Sales by Application (2018-2023) & (K Boxes)
Table 11. Global Paliperidone Extended Release Tablets Sales Market Share by Application (2018-2023)
Table 12. Global Paliperidone Extended Release Tablets Revenue by Application (2018-2023)
Table 13. Global Paliperidone Extended Release Tablets Revenue Market Share by Application (2018-2023)
Table 14. Global Paliperidone Extended Release Tablets Sale Price by Application (2018-2023) & (US$/Box)
Table 15. Global Paliperidone Extended Release Tablets Sales by Company (2018-2023) & (K Boxes)
Table 16. Global Paliperidone Extended Release Tablets Sales Market Share by Company (2018-2023)
Table 17. Global Paliperidone Extended Release Tablets Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Paliperidone Extended Release Tablets Revenue Market Share by Company (2018-2023)
Table 19. Global Paliperidone Extended Release Tablets Sale Price by Company (2018-2023) & (US$/Box)
Table 20. Key Manufacturers Paliperidone Extended Release Tablets Producing Area Distribution and Sales Area
Table 21. Players Paliperidone Extended Release Tablets Products Offered
Table 22. Paliperidone Extended Release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Paliperidone Extended Release Tablets Sales by Geographic Region (2018-2023) & (K Boxes)
Table 26. Global Paliperidone Extended Release Tablets Sales Market Share Geographic Region (2018-2023)
Table 27. Global Paliperidone Extended Release Tablets Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Paliperidone Extended Release Tablets Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Paliperidone Extended Release Tablets Sales by Country/Region (2018-2023) & (K Boxes)
Table 30. Global Paliperidone Extended Release Tablets Sales Market Share by Country/Region (2018-2023)
Table 31. Global Paliperidone Extended Release Tablets Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Paliperidone Extended Release Tablets Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Paliperidone Extended Release Tablets Sales by Country (2018-2023) & (K Boxes)
Table 34. Americas Paliperidone Extended Release Tablets Sales Market Share by Country (2018-2023)
Table 35. Americas Paliperidone Extended Release Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Paliperidone Extended Release Tablets Revenue Market Share by Country (2018-2023)
Table 37. Americas Paliperidone Extended Release Tablets Sales by Type (2018-2023) & (K Boxes)
Table 38. Americas Paliperidone Extended Release Tablets Sales by Application (2018-2023) & (K Boxes)
Table 39. APAC Paliperidone Extended Release Tablets Sales by Region (2018-2023) & (K Boxes)
Table 40. APAC Paliperidone Extended Release Tablets Sales Market Share by Region (2018-2023)
Table 41. APAC Paliperidone Extended Release Tablets Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Paliperidone Extended Release Tablets Revenue Market Share by Region (2018-2023)
Table 43. APAC Paliperidone Extended Release Tablets Sales by Type (2018-2023) & (K Boxes)
Table 44. APAC Paliperidone Extended Release Tablets Sales by Application (2018-2023) & (K Boxes)
Table 45. Europe Paliperidone Extended Release Tablets Sales by Country (2018-2023) & (K Boxes)
Table 46. Europe Paliperidone Extended Release Tablets Sales Market Share by Country (2018-2023)
Table 47. Europe Paliperidone Extended Release Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Paliperidone Extended Release Tablets Revenue Market Share by Country (2018-2023)
Table 49. Europe Paliperidone Extended Release Tablets Sales by Type (2018-2023) & (K Boxes)
Table 50. Europe Paliperidone Extended Release Tablets Sales by Application (2018-2023) & (K Boxes)
Table 51. Middle East & Africa Paliperidone Extended Release Tablets Sales by Country (2018-2023) & (K Boxes)
Table 52. Middle East & Africa Paliperidone Extended Release Tablets Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Paliperidone Extended Release Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Paliperidone Extended Release Tablets Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Paliperidone Extended Release Tablets Sales by Type (2018-2023) & (K Boxes)
Table 56. Middle East & Africa Paliperidone Extended Release Tablets Sales by Application (2018-2023) & (K Boxes)
Table 57. Key Market Drivers & Growth Opportunities of Paliperidone Extended Release Tablets
Table 58. Key Market Challenges & Risks of Paliperidone Extended Release Tablets
Table 59. Key Industry Trends of Paliperidone Extended Release Tablets
Table 60. Paliperidone Extended Release Tablets Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Paliperidone Extended Release Tablets Distributors List
Table 63. Paliperidone Extended Release Tablets Customer List
Table 64. Global Paliperidone Extended Release Tablets Sales Forecast by Region (2024-2029) & (K Boxes)
Table 65. Global Paliperidone Extended Release Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Paliperidone Extended Release Tablets Sales Forecast by Country (2024-2029) & (K Boxes)
Table 67. Americas Paliperidone Extended Release Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Paliperidone Extended Release Tablets Sales Forecast by Region (2024-2029) & (K Boxes)
Table 69. APAC Paliperidone Extended Release Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Paliperidone Extended Release Tablets Sales Forecast by Country (2024-2029) & (K Boxes)
Table 71. Europe Paliperidone Extended Release Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Paliperidone Extended Release Tablets Sales Forecast by Country (2024-2029) & (K Boxes)
Table 73. Middle East & Africa Paliperidone Extended Release Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Paliperidone Extended Release Tablets Sales Forecast by Type (2024-2029) & (K Boxes)
Table 75. Global Paliperidone Extended Release Tablets Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Paliperidone Extended Release Tablets Sales Forecast by Application (2024-2029) & (K Boxes)
Table 77. Global Paliperidone Extended Release Tablets Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Janssen Pharmaceutical Basic Information, Paliperidone Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Janssen Pharmaceutical Paliperidone Extended Release Tablets Product Portfolios and Specifications
Table 80. Janssen Pharmaceutical Paliperidone Extended Release Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 81. Janssen Pharmaceutical Main Business
Table 82. Janssen Pharmaceutical Latest Developments
Table 83. Cspc Ouyi Pharmaceutical Co., Ltd. Basic Information, Paliperidone Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Cspc Ouyi Pharmaceutical Co., Ltd. Paliperidone Extended Release Tablets Product Portfolios and Specifications
Table 85. Cspc Ouyi Pharmaceutical Co., Ltd. Paliperidone Extended Release Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 86. Cspc Ouyi Pharmaceutical Co., Ltd. Main Business
Table 87. Cspc Ouyi Pharmaceutical Co., Ltd. Latest Developments
Table 88. Hansoh Pharmaceutical Group Company Limited Basic Information, Paliperidone Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. Hansoh Pharmaceutical Group Company Limited Paliperidone Extended Release Tablets Product Portfolios and Specifications
Table 90. Hansoh Pharmaceutical Group Company Limited Paliperidone Extended Release Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 91. Hansoh Pharmaceutical Group Company Limited Main Business
Table 92. Hansoh Pharmaceutical Group Company Limited Latest Developments
Table 93. Shenzhen Kangzhe Biotechnology Co., Ltd. Basic Information, Paliperidone Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 94. Shenzhen Kangzhe Biotechnology Co., Ltd. Paliperidone Extended Release Tablets Product Portfolios and Specifications
Table 95. Shenzhen Kangzhe Biotechnology Co., Ltd. Paliperidone Extended Release Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 96. Shenzhen Kangzhe Biotechnology Co., Ltd. Main Business
Table 97. Shenzhen Kangzhe Biotechnology Co., Ltd. Latest Developments
Table 98. Haisco Pharmaceutical Group Co., Ltd. Basic Information, Paliperidone Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Haisco Pharmaceutical Group Co., Ltd. Paliperidone Extended Release Tablets Product Portfolios and Specifications
Table 100. Haisco Pharmaceutical Group Co., Ltd. Paliperidone Extended Release Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 101. Haisco Pharmaceutical Group Co., Ltd. Main Business
Table 102. Haisco Pharmaceutical Group Co., Ltd. Latest Developments
Table 103. Sun Pharmaceutical Basic Information, Paliperidone Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Sun Pharmaceutical Paliperidone Extended Release Tablets Product Portfolios and Specifications
Table 105. Sun Pharmaceutical Paliperidone Extended Release Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 106. Sun Pharmaceutical Main Business
Table 107. Sun Pharmaceutical Latest Developments
Table 108. Teva Basic Information, Paliperidone Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 109. Teva Paliperidone Extended Release Tablets Product Portfolios and Specifications
Table 110. Teva Paliperidone Extended Release Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 111. Teva Main Business
Table 112. Teva Latest Developments
Table 113. Lupin Basic Information, Paliperidone Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 114. Lupin Paliperidone Extended Release Tablets Product Portfolios and Specifications
Table 115. Lupin Paliperidone Extended Release Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 116. Lupin Main Business
Table 117. Lupin Latest Developments
List of Figures
Figure 1. Picture of Paliperidone Extended Release Tablets
Figure 2. Paliperidone Extended Release Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paliperidone Extended Release Tablets Sales Growth Rate 2018-2029 (K Boxes)
Figure 7. Global Paliperidone Extended Release Tablets Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Paliperidone Extended Release Tablets Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 3mg
Figure 10. Product Picture of 6mg
Figure 11. Global Paliperidone Extended Release Tablets Sales Market Share by Type in 2022
Figure 12. Global Paliperidone Extended Release Tablets Revenue Market Share by Type (2018-2023)
Figure 13. Paliperidone Extended Release Tablets Consumed in Hospital
Figure 14. Global Paliperidone Extended Release Tablets Market: Hospital (2018-2023) & (K Boxes)
Figure 15. Paliperidone Extended Release Tablets Consumed in Psychiatric Hospital
Figure 16. Global Paliperidone Extended Release Tablets Market: Psychiatric Hospital (2018-2023) & (K Boxes)
Figure 17. Paliperidone Extended Release Tablets Consumed in Other
Figure 18. Global Paliperidone Extended Release Tablets Market: Other (2018-2023) & (K Boxes)
Figure 19. Global Paliperidone Extended Release Tablets Sales Market Share by Application (2022)
Figure 20. Global Paliperidone Extended Release Tablets Revenue Market Share by Application in 2022
Figure 21. Paliperidone Extended Release Tablets Sales Market by Company in 2022 (K Boxes)
Figure 22. Global Paliperidone Extended Release Tablets Sales Market Share by Company in 2022
Figure 23. Paliperidone Extended Release Tablets Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Paliperidone Extended Release Tablets Revenue Market Share by Company in 2022
Figure 25. Global Paliperidone Extended Release Tablets Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Paliperidone Extended Release Tablets Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Paliperidone Extended Release Tablets Sales 2018-2023 (K Boxes)
Figure 28. Americas Paliperidone Extended Release Tablets Revenue 2018-2023 ($ Millions)
Figure 29. APAC Paliperidone Extended Release Tablets Sales 2018-2023 (K Boxes)
Figure 30. APAC Paliperidone Extended Release Tablets Revenue 2018-2023 ($ Millions)
Figure 31. Europe Paliperidone Extended Release Tablets Sales 2018-2023 (K Boxes)
Figure 32. Europe Paliperidone Extended Release Tablets Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Paliperidone Extended Release Tablets Sales 2018-2023 (K Boxes)
Figure 34. Middle East & Africa Paliperidone Extended Release Tablets Revenue 2018-2023 ($ Millions)
Figure 35. Americas Paliperidone Extended Release Tablets Sales Market Share by Country in 2022
Figure 36. Americas Paliperidone Extended Release Tablets Revenue Market Share by Country in 2022
Figure 37. Americas Paliperidone Extended Release Tablets Sales Market Share by Type (2018-2023)
Figure 38. Americas Paliperidone Extended Release Tablets Sales Market Share by Application (2018-2023)
Figure 39. United States Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Paliperidone Extended Release Tablets Sales Market Share by Region in 2022
Figure 44. APAC Paliperidone Extended Release Tablets Revenue Market Share by Regions in 2022
Figure 45. APAC Paliperidone Extended Release Tablets Sales Market Share by Type (2018-2023)
Figure 46. APAC Paliperidone Extended Release Tablets Sales Market Share by Application (2018-2023)
Figure 47. China Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Paliperidone Extended Release Tablets Sales Market Share by Country in 2022
Figure 55. Europe Paliperidone Extended Release Tablets Revenue Market Share by Country in 2022
Figure 56. Europe Paliperidone Extended Release Tablets Sales Market Share by Type (2018-2023)
Figure 57. Europe Paliperidone Extended Release Tablets Sales Market Share by Application (2018-2023)
Figure 58. Germany Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Paliperidone Extended Release Tablets Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Paliperidone Extended Release Tablets Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Paliperidone Extended Release Tablets Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Paliperidone Extended Release Tablets Sales Market Share by Application (2018-2023)
Figure 67. Egypt Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Paliperidone Extended Release Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Paliperidone Extended Release Tablets in 2022
Figure 73. Manufacturing Process Analysis of Paliperidone Extended Release Tablets
Figure 74. Industry Chain Structure of Paliperidone Extended Release Tablets
Figure 75. Channels of Distribution
Figure 76. Global Paliperidone Extended Release Tablets Sales Market Forecast by Region (2024-2029)
Figure 77. Global Paliperidone Extended Release Tablets Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Paliperidone Extended Release Tablets Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Paliperidone Extended Release Tablets Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Paliperidone Extended Release Tablets Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Paliperidone Extended Release Tablets Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のパリペリドン徐放性錠剤市場予測 2023年-2029年] (コード：LP23DC02974)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のパリペリドン徐放性錠剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の塩酸オキシコドン徐放性錠剤市場予測 2023年-2029年
  • 世界のメトプロロールコハク酸塩徐放錠市場予測 2023年-2029年
  • 世界の塩酸オキシコドン徐放性薬剤市場予測 2023年-2029年
  • 世界のシャオシュアン銅鑼錠市場予測 2023年-2029年
  • 世界のゾピクロン錠市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆